Core Scientific, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 126.91 million compared to USD 163.97 million a year ago. Net loss was USD 9.26 million compared to USD 810.48 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 2.49 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 2.49 a year ago.
For the six months, revenue was USD 247.57 million compared to USD 356.49 million a year ago. Net loss was USD 9.65 million compared to USD 1,276.68 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 4.04 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 4.04 a year ago.